{"transactions":[{"id":962212,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This stock option shall vest in equal monthly installments over a four year period, subject to the Reporting Person's continuing service to the Issuer through such dates."}],"balance_after":65000,"derivative":{"exercise_price":39.45,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962211,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":94800,"price":39.45,"value":3739860.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings in connection with the vesting of the 2023 PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":216650,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962210,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":214000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents acquisition of shares of common stock in connection with the vesting of a performance-based RSU award granted in February 2023 (the \"2023 PSUs\")."}],"balance_after":311450,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":962209,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-12-19T16:01:08.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,602 shares of common stock acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on June 30, 2025."}],"balance_after":97450,"source":{"system":"sec-edgar","filing":"0001193125-25-326774","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000119312525326774/ownership.xml","form_type":"4"}},{"id":1294626,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T17:00:07.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a four year period."}],"balance_after":240000,"derivative":{"exercise_price":8.89,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0000950170-25-009266","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017025009266/ownership.xml","form_type":"4"}},{"id":1302754,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-15T07:00:04.000Z","date":"2025-01-14","kind":"purchase","planned":false,"acquired":true,"shares":43750,"price":7.598,"value":332412.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $7.53 to $7.60.  Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,398 shares acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan on December 31, 2024."}],"balance_after":45848,"source":{"system":"sec-edgar","filing":"0000950170-25-005630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017025005630/ownership.xml","form_type":"4"}},{"id":1499392,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":71110,"kind":"person","name":"Pinnow Cole","position":1,"cik":"0002024135","reported_name":"Pinnow Cole","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T16:03:03.000Z","date":"2024-05-25","kind":"grant","planned":false,"acquired":true,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest 25% on the first anniversary of May 25, 2024, with the remainder vesting in equal monthly installments through May 25, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":525000,"derivative":{"exercise_price":8.22,"expiration_date":"2034-05-25","underlying":"Common Stock","underlying_shares":525000},"source":{"system":"sec-edgar","filing":"0000950170-24-065900","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024135/000095017024065900/ownership.xml","form_type":"4"}}]}